Trial · NCT01513187
Pazopanib in Combination With Interferon Alfa 2-A, in Patients With Advanced Renal Cell Carcinoma
NCT01513187, Phase 1, Phase 2, Completed, Spanish Oncology Genito-Urinary Group
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Pazopanib in Combination With Interferon Alfa 2-A, in Patients With Advanced Renal Cell Carcinoma. Trials, record NCT01513187. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT01513187
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Pazopanib in Combination With Interferon Alfa 2-A, in Patients With Advanced Renal Cell Carcinoma
- NCT number
- NCT01513187
- Status
- Completed
- Phases
- Phase 1, Phase 2
- Enrollment
- 53 participants, actual
- Lead sponsor
- Spanish Oncology Genito-Urinary Group
- Conditions
- Advanced Renal Cell Carcinoma
- Interventions
- Pazopanib + interferon alpha 2A
- First posted
- 2012-01-20
- Last updated
- 2022-03-10
Source ClinicalTrials.gov
Registered outcomes6
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Maximum tolerated dose (MTD) - Phase I | Up to September 2012 | The MTD is defined as the dose at wich two of the patients have experienced dose-limiting toxicity. |
| Primary | Efficacy, response rate (Phase II) | Up to July 2013 | Response rate is defined as the percentage of patients with complete response or partial response confirmed according RECIST v.1.1 |
| Secondary | Progression free survival | Up to July 2013 | Period between the start of treatment until the day in in wich the progression is confirmed by RECIST guidelines (version 1.1) or death from any cause. |
| Secondary | Overall Survival | Up to December 2013 | Period between the start of treatment and date of death from any cause. |
| Secondary | Frequency of adverse events | Up to July 2013 | Toxicity evaluation of the combination using the NCI-CTC Criteria version 3.0 |
| Secondary | Translational Substudy | Up to December 2013 | To analyze the different biomarkers and their variations with clinical outcomes of patients. |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT01513187
GET https://conductscience.org/api/trials/v1/NCT01513187/registered